Removal of DATA Waiver (X-Waiver) Requirement
Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD). With this provision, and effective immediately, SAMHSA will no longer be accepting NOIs (waiver applications).
CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Now Open for Public Comment
CDC’s draft updated Clinical Practice Guideline for Prescribing Opioids is open for public comment now through April 11, 2022. Please add your feedback on this important update: https://go.usa.gov/xtAW5
American Medical Association Releases Overdose Toolkit
The American Medical Association has released a toolkits that recommends states expand treatment of opioid use disorder in Medicaid and commercial insurance and remove barriers, such as prior authorization and other utilization management policies. Additionally, treatment must address disparities and the needs of all patients equitably, including vulnerable populations. The toolkit also highlights the importance […]
Thank you for your patience while we make improvements
PCSS is in the midst of updating its learner management system with the goal of making your life easier. While we do this, we’re encountering a few bumps in the road. Ultimately, we hope your learning experience is more seamless while we continue to offer webinars, clinical round tables, and all the other trainings you’ve […]
Telehealth for Opioid Use Disorder Toolkit: Guidance to Support High-Quality Care
View the Telehealth for OUD Toolkit
DEA Issues Urgent Message About Lethal Fake Prescription Drugs
WASHINGTON, DC –Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide surge in counterfeit pills that are […]
2021 National Opioid & Substance Awareness Day – September 21, 2021
Join National Opioid and Substance Awareness Day’s virtual town hall on September 21 @ 12-3pm EDT Register and learn more
Biden Administration Approves Funding to Combat OUD in Rural Areas
Today, the Biden-Harris Administration announced that it is providing nearly $90 million to help rural communities combat opioid use disorders (OUD) and other forms of substance use disorders (SUD), and to improve access to maternal and obstetrics care. This funding is being distributed by the U.S. Department of Health and Human Services (HHS) through the […]
SUD Treatment and Recovery Loan Repayment Program
This week, the Health Resources and Services Administration (HRSA) announced a new Substance Use Disorder Treatment and Recovery Loan Repayment Program (STAR LRP), open now through July 22, 2021, at 7:30 pm ET. The program will repay educational loans for eligible staff up to $250,000 for six years of work. Join HRSA’s STAR LRP application […]
Biden-Harris Administration Calls for Historic Levels of Funding to Address Addiction and Overdose
The Biden-Harris Administration submitted to Congress the President’s Budget for fiscal year (FY) 2022. The Budget invests an unprecedented $41 billion in public safety and public health approaches to address addiction and the overdose epidemic, including significant increases for prevention and treatment of substance use disorders. Within the budget, more than 57% of all requested […]
